STAT3 and breast carcinoma: Other compounds, including C‐pTyr–Leu–Pro–Gln–Thr–Val–NH2, BP–PM6, BP–PM7, and PMM‐172, have been shown to suppress STAT3 by reducing its persistent phosphorylation in HNSCC and breast cancer through SH2 domain inhibition [27].